Pfizer (NYSE: PFE) was on top of the world when it came to earnings and stock price performance. This was in early pandemic ...

Ocugen (OCGN) is grabbing investors’ attention with its stock climbing 195% in the past year and its modifier gene therapy platform, which promises to deliver one-time treatments that could ...

“This device represents one of the most significant advancements in Avinger’s image-guided technologies for the treatment of peripheral artery disease,” said Chief Medical Officer Jaafer Golzar.